EcoR1 Capital, LLC 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:15 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | EcoR1 Capital, LLC | 253,897 1.700% | -111,111 (-30.44%) | Filing |
| 2021-02-12 4:15 pm Purchase | 2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS | EcoR1 Capital, LLC | 365,008 5.400% | 132,744 (+57.15%) | Filing |